HighCape Capital, L.P. - Jun 8, 2023 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role
Director, 10%+ Owner
Signature
/s/ Kevin L. Rakin
Stock symbol
ELUT
Transactions as of
Jun 8, 2023
Transactions value $
$0
Form type
4
Date filed
6/12/2023, 03:32 PM
Previous filing
Dec 27, 2022
Next filing
Oct 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELUT Stock Option (Right to Buy) Award $0 +37.5K $0.00 37.5K Jun 8, 2023 Class A Common Stock 37.5K $2.37 See footnote F1, F2
transaction ELUT Stock Option (Right to Buy) Award $0 +25K $0.00 25K Jun 8, 2023 Class A Common Stock 25K $2.37 See footnote F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted automatically under the Issuer's First Amended and Restated Non-Employee Director Compensation Policy and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to Messrs. Rakin's and Zuga's, as applicable, continuing in service on the Issuer's board of directors through the applicable vesting date.
F2 Held by Kevin L. Rakin as non-employee member of the Issuer's board of directors.
F3 Held by W. Matthew Zuga as non-employee member of the Issuer's board of directors.